Additional support that SOX9 may be an important early event in the development of Barrett's tumorigenesis is seen in the activation of SOX9 following loss of β2-spectrin, which induces a TGFβ signaling switch from tumor suppressor in normal cells to tumor promoter in fibroblasts and EACs [27]. The gene discussed is TGFB1; the disease is neoplasm.